ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,987, issued on Nov. 4, was assigned to DUKE UNIVERSITY (Durham, N.C.) and ALBERT EINSTEIN COLLEGE OF MEDICINE (Bronx, N.Y.).

"Monoclonal antibodies for prevention and treatment of herpes simplex viral infections" was invented by Betsy C. Herold (Rowayton, Conn.), Garnett Kelsoe (Durham, N.C.), Masayuki Kuraoka (Durham, N.C.), Clare Burn (Bronx, N.Y.) and William R. Jacobs Jr. (Bronx, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies and antigen-binding fragments which bind to herpes simplex virus-2 (HSV-2), methods of use employing the antibodies and/or antigen-binding fragments, and pharmaceutical compositions comprising th...